St. Louis-Mallinckrodt introduces the Liebel-Flarsheim Hydra Vision Plus DR urological imaging system with optional liquid crystal display (LCD) viewing technology. Incorporating the features of the Hydra Vision Plus DR, the new LCD monitor option includes a lightweight triple articulating arm with ergonomic handles for easy movement, according to the company.
Vobramitamab duocarmazine continues to show promise in mCRPC
May 10th 2024Updated data from the phase 2 TAMARCK study continued to show safety and preliminary efficacy with the B7-H3–targeting antibody-drug conjugate vobramitamab duocarmazine in patients with metastatic castration-resistant prostate cancer.